<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02817321</url>
  </required_header>
  <id_info>
    <org_study_id>cuixulei2</org_study_id>
    <nct_id>NCT02817321</nct_id>
  </id_info>
  <brief_title>Thoracic Paravertebral Block : Effect on Acute Pain and Chronic Pain of Hepatectomy With Right J-shape Subcostal Incision</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cui Xulei</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Peking Union Medical College Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This prospective, randomized study,control study aims to compare the analgesic effect,opioids
      consumption,quality of recovery,length of hospital stay and incidence of chronic pain,et al.
      single-injection TPVB +continuous(pulsatile infusion) TPVB and intravenous patient-controlled
      analgesia (IPCA) alone in patients undergoing hepatectomy with right J-shape subcostal
      incision.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 2016</start_date>
  <completion_date type="Actual">November 2018</completion_date>
  <primary_completion_date type="Actual">October 31, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>cumulative morphine consumption</measure>
    <time_frame>within 48 postoperative hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>The pain scores determined by the numeric rating scale (NRS, 0-10)</measure>
    <time_frame>At 0, 2,4, 8, 12, 24 ,48,72hours and 7day after the surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>nausea and vomiting score</measure>
    <time_frame>At 0, 2,4, 8, 12, 24 and 48hours after the surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>pruritus score</measure>
    <time_frame>At 0, 2,4, 8, 12, 24 and 48hours after the surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ambulation time</measure>
    <time_frame>within the 7 days after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>time of recovery of bowl movement</measure>
    <time_frame>within the 7 days after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative hospital length of stay</measure>
    <time_frame>Up to 4 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>patient satisfaction with anesthesia</measure>
    <time_frame>48 hours after surgery</time_frame>
    <description>use the Chinese version Bauer questionnaire to assess the patient satisfaction with anesthesia</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>data collection of chronic pain</measure>
    <time_frame>at 3,6,12 months after surgery</time_frame>
    <description>Patients undergo a telephone interview with a questionnaire at 3, 6 and 12 months after surgery, the incidence and severity of chronic pain is recorded.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">76</enrollment>
  <condition>Hepatectomy</condition>
  <condition>Analgesia</condition>
  <condition>Nerve Block</condition>
  <arm_group>
    <arm_group_label>Single-injection TPVB +continuous TPVB</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Single-injection of TPVB is given preoperatively followed with continuous infusion+ postoperative IPCA.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>IPCA</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>postoperative IPCA is given alone</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>single-injection TPVB + continuous TPVB</intervention_name>
    <description>Inject local anesthetics in the T8 paravertebral space followed with catheter insertion and continuous local infusion.</description>
    <arm_group_label>Single-injection TPVB +continuous TPVB</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Philip CX50 Ultrasound Scanner</intervention_name>
    <description>The curved (C1-5) probe of Philip CX 50 Ultrasound Scanner is used for scanning</description>
    <arm_group_label>Single-injection TPVB +continuous TPVB</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>PAJUNK Contiplex S Catheter</intervention_name>
    <arm_group_label>Single-injection TPVB +continuous TPVB</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>single dose ropivacaine</intervention_name>
    <description>2mg/kg ropivacaine in saline with 1:200,000 adrenaline, 25ml in total
given immediately after the correct position of the tip of the needle has been confirmed</description>
    <arm_group_label>Single-injection TPVB +continuous TPVB</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>continuously infusion of ropivacaine</intervention_name>
    <description>0.2% ropivacaine, pulse dosadge: 0.125ml/kg/pulse, 1pulse/h at a rate of 6ml/minutes
given through the catheter inserted in the T8 paravertebral space following the single dose</description>
    <arm_group_label>Single-injection TPVB +continuous TPVB</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Morphine given as IPCA</intervention_name>
    <description>bolus: 2mg, lock time: 10min, 1h limitation: 8mg</description>
    <arm_group_label>IPCA</arm_group_label>
    <arm_group_label>Single-injection TPVB +continuous TPVB</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 18-70 yrs

          -  American Society of Anesthesiologists physical statusⅠ-Ⅲ

          -  Undergo hepatectomy with J-shape subcostal incision

          -  Informed consent

        Exclusion Criteria:

          -  A known allergy to the drugs being used

          -  Coagulopathy, on anticoagulants

          -  Analgesics intake, history of substance abuse

          -  Participating in the investigation of another experimental agent

          -  Inability to properly describe postoperative pain to investigators (eg, language
             barrier, neuropsychiatric disorder)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yuguang Huang, MD.</last_name>
    <role>Study Chair</role>
    <affiliation>Peking Union Medical College Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Xulei CUI</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100730</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>January 2019</verification_date>
  <study_first_submitted>June 22, 2016</study_first_submitted>
  <study_first_submitted_qc>June 25, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 29, 2016</study_first_posted>
  <last_update_submitted>January 6, 2019</last_update_submitted>
  <last_update_submitted_qc>January 6, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">January 8, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Peking Union Medical College Hospital</investigator_affiliation>
    <investigator_full_name>Cui Xulei</investigator_full_name>
    <investigator_title>Attending physician</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Morphine</mesh_term>
    <mesh_term>Ropivacaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

